- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00655720
The Effects on Growth of a Non-Routine Infant Formula
April 10, 2008 updated by: Mead Johnson Nutrition
The Effects on Growth and Tolerance of Hydrolyzed Formulas Fed to Term Infants
A study to evaluate the growth and development of term infants fed either an extensively hydrolyzed formula with probiotics, a partially hydrolyzed formula with probiotics, or an extensively hydrolyzed formula without probiotics
Study Overview
Study Type
Interventional
Enrollment (Actual)
293
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 2 weeks (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Term infant
- Solely formula fed
- 14 days of age
Exclusion Criteria:
- History of underlying disease
- Evidence of formula intolerance
- Current illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 2
|
Other Names:
|
|
Experimental: 3
|
Other Names:
|
|
Active Comparator: 1
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Growth (weight)
Time Frame: 106 days
|
106 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Tolerance
Time Frame: 106 days
|
106 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Deolinda Scalabrin, MD, Mead Johnson Nutrition
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2006
Primary Completion (Actual)
May 1, 2007
Study Completion (Actual)
May 1, 2007
Study Registration Dates
First Submitted
March 28, 2008
First Submitted That Met QC Criteria
April 9, 2008
First Posted (Estimate)
April 10, 2008
Study Record Updates
Last Update Posted (Estimate)
April 15, 2008
Last Update Submitted That Met QC Criteria
April 10, 2008
Last Verified
April 1, 2008
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 3369-5
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Growth
-
University of California, DavisCompletedGrowth Acceleration | Growth RetardationUnited States
-
Northwell HealthRecruitingGrowth | Growth Disorders | Growth Failure | Growth Hormone TreatmentUnited States
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyFrance
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in ChildrenIsrael, Denmark, Belgium, Spain, Macedonia, The Former Yugoslav Republic of, Turkey, United Kingdom, France, Slovenia, Czech Republic
-
Novo Nordisk A/SWithdrawnGrowth Hormone Disorder | Growth Hormone Deficiency in Children
-
Novo Nordisk A/SCompletedHealthy | Growth Hormone Disorder | Adult Growth Hormone DeficiencyUnited States
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in Children | Delivery SystemsGermany, Netherlands, Sweden
Clinical Trials on infant formula
-
Jovie USA, LLCIQVIA RDS Inc.; ObvioHealthCompleted
-
Société des Produits Nestlé (SPN)University College, LondonCompletedGrowth | Infant FormulaUnited Kingdom
-
Nara OrganicsPaidion Research, Inc.Completed
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Société des Produits Nestlé (SPN)Completed
-
Laboratorios OrdesaUnknownInfant DevelopmentSpain